Blueprint Mixed Reality Guidance System for shoulder arthroplasty offers surgeons a new tool to execute their pre-operative plan using 3D imaging and operate with more precision and consistencyKALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK), one of
MONTRÉAL--(BUSINESS WIRE)--Mr. Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce the arrival of Mr. Frédérick Perrault, CPA, CA, M. Sc., as an investor, strategic advisor, and member of the company’s board of directors. “We
Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced teamSASKATOON, Saskatchewan--(BUSINESS WIRE)--ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced certain preliminary, unaudited financial results for the year ended December 31,
With help from Gurobi, Fonterra uses its new planning model to sustainably produce nearly a third of the world’s dairy exports.BEAVERTON, Ore.--(BUSINESS WIRE)--#DecisionIntelligence--Gurobi Optimization, LLC, the leader in decision intelligence techno
Michael Gottlieb appointed as Chairman of the Board of Directors Dr. Anthony Johnson appointed as President and Chief Executive Officer STRASBOURG, France & MONTREAL & BOSTON--(BUSINESS WIRE)--Domain Therapeutics (“Domain” or “the Company”), a
Highlights Long term, multi-year supply agreement provides Alpha-9 with NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Alpha-9’s targeted radiopharmaceutical programs for treatment of solid and liquid tumors. Agreement will
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today provided a corporate update and highlighted key milestones anticipated in
- Intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects at lower doses compared to native DMT, suggesting potential as a short-acting, scalable treatment - - Intramuscular (“IM”) dosing of SPL028 produced robust, short
Donations to Breast Cancer Canada directly translate to more time in the lab for Canadian research teams.TORONTO--(BUSINESS WIRE)--Breast Cancer Canada (BCC), a national charity dedicated to saving lives through breast cancer research, is proud to announ
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.